Simpirica Spine website
Simpirica Spine Closes $22 Million Series C Funding Led by Norwest Venture Partners (press release)
Simpirica Spine, Inc., developer of minimally invasive, flexion-restricting stabilization devices for the spine, today announced the closing of a $22 million Series C round of venture funding, led by new investor Norwest Venture Partners (NVP). Existing investors De Novo Ventures and U.S. Venture Partners (USVP) also participated in this round, which will be used to support the European commercialization of the company’s lead product, the LimiFlex Spinal Stabilization System.
“The closing of this round validates the venture community’s continued confidence in Simpirica Spine’s team and its ability to fulfill the promise of flexion-restricting stabilization to improve clinical outcomes for patients and surgeons around the globe”
Simpirica Spine was founded in 2006 to develop minimally invasive, flexion-restricting stabilization devices for the spine. Flexion (forward bending) of the lumbar spine can lead to pain or instability for more than 400,000 patients per year worldwide. Outside the U.S., the LimiFlex Spinal Stabilization Sys...
